Tetsuhiro Kasamatsu

14PUBLICATIONS
12CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 13, 2025
Role of Rac1 in p53-Related Proliferation and Drug Sensitivity in Multiple Myeloma.

Ikuko Matsumura, Tsukasa Oda, Tetsuhiro Kasamatsu

|Nov 13, 2024
APEX1 Polymorphisms Affect Acute Myeloid Leukemia Risk, and Its Expression Is Involved in Cell Proliferation and Differentiation.

Nanami Gotoh, Tsukasa Oda, Yuya Kitamura

|Dec 23, 2023
Implications of Senescent T Cells for Cancer Immunotherapy.

Tetsuhiro Kasamatsu

|Mar 13, 2023
Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression.

Tetsuhiro Kasamatsu, Maaya Awata-Shiraiwa, Rei Ishihara

|Feb 11, 2023
Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression.

Rei Ishihara, Tsukasa Oda, Yuki Murakami

|Jan 16, 2023
DNA damage-induced cellular senescence is regulated by 53BP1 accumulation in the nuclear foci and phase separation.

Tsukasa Oda, Nanami Gotoh, Tetsuhiro Kasamatsu

Pageof 3

Frequent Collaborators

9 joint publications

Hiroshi Handa

5 joint publications

Takayuki Saitoh

5 joint publications

Tsukasa Oda

4 joint publications

Nobuo Sasaki